Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEETS

v3.7.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
May 31, 2017
Aug. 31, 2016
Current    
Cash $ 2,788,978 $ 93,409
Accounts and other receivables 57,398 131,083
Inventory 128,381 134,724
Prepaid expenses and deposit 104,523 150,950
Total Current Assets 3,079,280 510,166
Patents 63,044 53,997
Equipment 2,011 2,475
Total Noncurrent Assets 65,055 56,472
TOTAL ASSETS 3,144,335 566,638
Current    
Accounts payable and accrued liabilities 12,956 90,010
Unearned revenue 19,600 12,500
Due to related parties 7,446 331,371
Total Current Liabilities 40,002 433,881
Convertible debenture 45,000 45,000
TOTAL LIABILITIES 85,002 478,881
STOCKHOLDERS' EQUITY    
Share Capital Authorized: 220,000,000 common voting shares with a par value of $0.001 per share Issued and outstanding: 66,552,303 common shares at May 31, 2017 and 51,288,473 common shares at August 31, 2016 66,552 51,288
Additional paid-in capital 15,681,352 11,515,419
Deficit (12,483,019) (11,300,662)
Equity attributable to shareholders of the Company 3,264,885 266,045
Non-Controlling Interest (205,552) (178,288)
Total Stockholders' Equity 3,059,333 87,757
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 3,144,335 $ 566,638